In this episode of Build The Future, we talk with <a href='https://twitter.com/srikosuri'>Sri Kosuri</a>, CEO &amp; co-founder of <a href='https://www.octant.bio/'>Octant</a>. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases.  We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more! Links Mentioned <ul><li><a href='https://www.biospace.com/article/releases/octant-launches-polypharmacology-drug-discovery-engine-for-complex-diseases-with-30-million-series-a-financing-led-by-andreessen-horowitz/'>Octant Launches Polypharmacology Drug Discovery Engine for Complex Diseases with $30 Million Series A Financing Led by Andreessen Horowitz article on biospace.com</a></li></ul>To listen to more episodes and stay connected, follow along at:<ul><li><a href='https://www.buildthefuturepodcast.com/'>https://www.buildthefuturepodcast.com/</a></li><li><a href='https://twitter.com/camwiese'>https://twitter.com/camwiese</a></li></ul>Don’t forget to leave a review and subscribe. Have a great week and until next time, go build!

Dival Banerjee of Vuecason — The Future of 3D Printing, Metals, and Infrastructure

Build The Future shares the compelling visions of the future and the stories of those building it. We explore frontier technologies, innovative research, and ambitious projects from around the world that will shape our future. Our guests are entrepreneurs, thought leaders, researchers, and anyone else actively working to build the world we want to live in.